Milasinovic D, Mohl W. Contemporary perspective on endogenous myocardial regeneration. World J Stem Cells 2015; 7(5): 793-805 [PMID: 26131310 DOI: 10.4252/wjsc.v7.i5.793]
Corresponding Author of This Article
Werner Mohl, MD, PhD, Professor, Department of Cardiac Surgery, Medical University of Vienna, AKH Wien, Waehringerguertel 18-20, 1090 Vienna, Austria. werner.mohl@meduniwien.ac.at
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Stem Cells. Jun 26, 2015; 7(5): 793-805 Published online Jun 26, 2015. doi: 10.4252/wjsc.v7.i5.793
Contemporary perspective on endogenous myocardial regeneration
Dejan Milasinovic, Werner Mohl
Dejan Milasinovic, Department of Cardiology, Clinical Centre of Serbia, 11000 Belgrade, Serbia
Werner Mohl, Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria
Author contributions: Milasinovic D and Mohl W equally contributed to this paper.
Conflict-of-interest: Mohl W is the inventor of PICSO and founder (ownership interest) of Miracor Medical Systems; Milasinovic D has no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Werner Mohl, MD, PhD, Professor, Department of Cardiac Surgery, Medical University of Vienna, AKH Wien, Waehringerguertel 18-20, 1090 Vienna, Austria. werner.mohl@meduniwien.ac.at
Telephone: +43-140-40069890 Fax: +43-140-40067890
Received: December 13, 2014 Peer-review started: December 22, 2014 First decision: January 20, 2015 Revised: March 1, 2015 Accepted: April 16, 2015 Article in press: April 20, 2015 Published online: June 26, 2015 Processing time: 199 Days and 3.8 Hours
Core Tip
Core tip: Unlike in primitive vertebrates, any regenerative effort in adult mammalian hearts after an acute event remains unsatisfactory. Most efforts to repopulate failing hearts with functioning and integrated cardiomyocytes have not achieved clinical importance. In this overview, after describing several options for endogenous myocardial repair, we support the notion of a paradigm change towards inducible developmental processes in regeneration research. Major efforts have been made to convert tissues upstream in the Waddington scheme. Recently, stress transformed acquired pluripotency raised enormous expectations, but results and proof of concept were seriously questioned. We want to introduce pressure-controlled intermittent coronary sinus occlusion as a potential resource to decipher the unsolved equation of re-inducing the developmental processes in the human heart.
